Form 4 for WGS GeneDx Holdings Corp.
Accepted 2023-05-02 00:00:00 ET · period of report 2023-04-29 · accession 0001209191-23-026795 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-02 | 2023-04-29 | WGS | Stueland Katherine | CEO | M - OptEx | $0.00 | -511.4K | 819.9K | -38% | $0 |
| D | 2023-05-02 | 2023-04-29 | WGS | Stueland Katherine | CEO | M - OptEx | $0.00 | -511.4K | 1.53M | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-29 | M | D | 511,364 | $0.00 | 819,938 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2023-04-29 | M | D | 511,364 | $0.00 | 1,534,090 | D | — · — to — | 511,364 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 25% of the total shares underlying the restricted stock units vest on each of April 29, 2023 and April 29, 2024, and thereafter 6.25% of the total shares underlying the restricted stock units shall vest in equal quarterly installments until fully vested on April 29, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date. |